Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.
It was a rainy Thursday morning in Woonsocket, R.I., but that didn’t dissuade CVS Caremark stockholders from flocking to the company’s sprawling headquarters to attend its annual meeting of stockholders — an event that proved to be one filled with optimism as president and CEO Larry Merlo provided key highlights of 2011 and discussed how the company is reinventing pharmacy and capitalizing on its “integration sweet spots.”
Two speakers at the American Telemedicine Association’s annual meeting last week had positive words for the convenient care industry and essentially told attendees what Drug Store News has been saying for some time: Retail clinics are poised for significant growth.
The recent loss of business from a key specialty pharmacy customer and the continued deluge of generic introductions will represent significant challenges for Cardinal Health in fiscal year 2013 as it approaches the year-end of its fiscal 2012, company executives told analysts during a conference call Thursday morning.
CVS Caremark president and CEO Larry Merlo told analysts Wednesday morning that he was “very pleased” with the company's first quarter, as results across both the retail and pharmacy benefit management segments came in at the high end of expectations, and its integrated assets continue to demonstrate success and improve patient lives.
CVS Caremark announced today its partnership with The Miracle Project, a nonprofit organization that creates social skills programs for children with autism through the performing arts, to expand The Miracle Project School Inclusion Program to public schools in San Diego and San Jose, Calif.
The Drug Store News Group on Sunday co-hosted a breakfast with CVS Caremark. Larry Merlo, CVS Caremark president and CEO, shared with attendees CVS’ focus on leveraging personalization opportunities, through both marketing and assortment, to engender loyalty. And suppliers were introduced to new CVS/pharmacy president Mark Cosby and chief merchant Judy Sansone.
Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.
“You vs. Flu … you win with a flu shot!” Of course, patients aren’t the only winners now that pharmacies are actively touting their flu shot and other vaccination services. It’s quick. It’s easy. And it’s driving the number of flu shots delivered each season.
“We want to make sure we’re talking to our members where and how they want to be spoken to.” That was something Sam’s Club VP health and family care Jason Reiser said to me for the special report we did on the company that appeared on the cover of our April 2 issue.
CVS/pharmacy officially announced on Wednesday the April schedule of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities throughout 2012.
“Straight over the cliff.” That may be the destination for many independent pharmacies now that the Federal Trade Commission has unconditionally approved the controversial merger of the nation’s second- and third-largest pharmacy benefit managers, a top pharmacy leader warned.